Dr. Tedesco is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1700 Riverfront Ctr
Amsterdam, NY 12010Phone+1 518-843-0020Fax+1 518-843-0023
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- University of MichiganResidency, Internal Medicine, 1998 - 2001
- SUNY Upstate Medical UniversityClass of 1998
Certifications & Licensure
- NY State Medical License 2004 - 2025
- TN State Medical License 2001 - 2004
- MI State Medical License 1998 - 2001
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01
- Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Start of enrollment: 2013 Apr 01
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Join now to see all
Publications & Presentations
PubMed
- 79 citationsDocetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-In...Karen L. Tedesco, Ann D. Thor, David H. Johnson, Yu Shyr, K. A. Blum
Journal of Clinical Oncology. 2004-03-15 - 14 citationsProstate cancer early detection practices among men with a family history of disease.Cathryn H. Bock, Patricia A. Peyser, Stephen B. Gruber, Susan E. Bonnell, Karen L. Tedesco
Urology. 2003-09-01 - 13 citationsResults of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer.Kristi McIntyre, Patrick V. Acevedo, Carlos A. Encarnacion, Karen L. Tedesco, Yunfei Wang
Breast Cancer Research and Treatment. 2009-05-21
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: